Cerebral palsy.

Area of Science:

• Neurology
• Genetics
• Developmental Pediatrics

Background:

• Cerebral palsy (CP) is a permanent physical disability affecting movement and posture, stemming from early-life brain injuries or malformations.
• Genetic factors are now understood to contribute to up to 30% of CP cases.
• Prevalence rates have declined in high-income nations but remain higher in low- and middle-income countries.

Purpose of the Study:

• To review recent advancements in the diagnosis, prevention, and management of cerebral palsy.
• To highlight the impact of genetic contributions to CP.
• To emphasize the need for lifelong care and address challenges faced by adults with CP.

Main Methods:

• Review of current scientific literature and clinical evidence on cerebral palsy.
• Analysis of trends in CP prevalence and diagnostic capabilities.
• Synthesis of emerging therapeutic approaches, including medical, regenerative, and rehabilitation strategies.

Main Results:

• Significant progress has been made in diagnosing CP as early as 3 months of age, enabling timely interventions.
• New therapies are enhancing functional outcomes and participation for individuals with CP.
• A genetic contribution is identified in a substantial portion of individuals with CP.
• Prevalence has decreased by 40% in high-income countries, but remains higher in lower-income settings.

Conclusions:

• Early diagnosis and intensive intervention significantly improve outcomes for children and families affected by cerebral palsy.
• Emerging therapies offer new possibilities for enhancing function and participation throughout life.
• A comprehensive, lifelong approach to care is essential for individuals with cerebral palsy, addressing their evolving health needs.